About ALTG

About the ALTG

Who we are

The Australasian Lung Cancer Trials Group (ALTG) is an initiative of Lung Foundation Australia’s Lung Cancer National Program. This group was developed in 2004 and is Australia and New Zealand’s lung and thoracic cancer clinical research group.

The ALTG is a multi-disciplinary member-based organisation dedicated to reducing the incidence, morbidity and mortality of lung and other thoracic cancers and improving the quality of life of these patients, carers and families in Australia and New Zealand through the coordination and facilitation of high quality clinical research. Prospective members are invited to review the benefits of membership and join the ALTG.

The ALTG benefits from new and existing partnerships. The ALTG also collaborates with The National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC) and Peter MacCallum Cancer Centre. Both of these groups are leaders in Australia for the design, conduct, analysis and publication of oncology clinical trials, including working with both Australian and international collaborative groups.

ALTG Objectives

  • To facilitate participation in the development, conduct, evaluation, reporting of clinical trials in lung and thoracic cancer.
  • To promote the use of clinical trials in evaluating new treatments and management approaches for lung and thoracic cancer.
  • To contribute to the translation of clinical trial findings into clinical practice.

Find out more about the ALTG clinical research program and review the ALTG Research Report 2004-2016.